Cargando…

Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts

BPR0L075, 6-methoxy-3-(3′,4′,5′-trimethoxy-benzoyl)-1H-indole, is a tubulin-binding agent that inhibits tubulin polymerization by binding to the colchicine-binding site. BPR0L075 has shown antimitotic and antiangiogenic activity in vitro. The current study evaluated the vascular-disrupting activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Li, Beck, Haley, Wang, Xiaolei, Hsieh, Hsing-Pang, Mason, Ralph P., Liu, Xinli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427339/ https://www.ncbi.nlm.nih.gov/pubmed/22937031 http://dx.doi.org/10.1371/journal.pone.0043314

Ejemplares similares

An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells
por: Wang, Xiaolei, et al.
Publicado: (2013)

Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells
por: Tseng, Ho-Hsing, et al.
Publicado: (2012)

TBA-7 is not a microtubule-destabilizing tubulin
por: Lu, Yu-Ming, et al.
Publicado: (2021)

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity
por: Shih, Shin-Ru, et al.
Publicado: (2010)

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment
por: Shionome, Yoshimi, et al.
Publicado: (2013)

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment
por: Shionome, Yoshimi, et al.
Publicado: (2013)

Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule
por: Yang, Jianhong, et al.
Publicado: (2016)

EU Regulation of Nanobiocides: Challenges in Implementing the Biocidal Product Regulation (BPR)
por: Brinch, Anna, et al.
Publicado: (2016)

Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin
por: Sharma, Ashwani, et al.
Publicado: (2017)

Destabilizing an interacting motif strengthens the association of a designed ankyrin repeat protein with tubulin
por: Ahmad, Shoeb, et al.
Publicado: (2016)

BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2011)

Observation of the Effect of Nursing BPR on Thrombolytic Efficacy and Prognosis of Patients with Cerebral Infarction Based on CT Images
por: Wang, Shaomin, et al.
Publicado: (2022)

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
por: Lin, W-H, et al.
Publicado: (2012)

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
por: Lin, Wen-Hsing, et al.
Publicado: (2014)

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors †
por: Liu, Li, et al.
Publicado: (2021)

Characterization of BPSS1521 (bprD), a Regulator of Burkholderia pseudomallei Virulence Gene Expression in the Mouse Model
por: Chirakul, Sunisa, et al.
Publicado: (2014)

Acridine 0.75-hydrate
por: Schur, Einat, et al.
Publicado: (2011)

Chlamydomonas reinhardtii tubulin-gene disruptants for efficient isolation of strains bearing tubulin mutations
por: Kato-Minoura, Takako, et al.
Publicado: (2020)

The efficacy of 0.75% levobupivacaine versus 0.75% ropivacaine for peribulbar anesthesia in vitreoretinal surgery
por: Ghali, Ashraf M.
Publicado: (2012)

Perturbation of the two-component signal transduction system, BprRS, results in attenuated virulence and motility defects in Burkholderia pseudomallei
por: Lazar Adler, Natalie R., et al.
Publicado: (2016)

BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
por: Tsai, Hui‐Jen, et al.
Publicado: (2018)

Establishing a High-content Analysis Method for Tubulin Polymerization to Evaluate Both the Stabilizing and Destabilizing Activities of Compounds
por: Sum, Chi Shing, et al.
Publicado: (2014)

LBODP075 Vanishing Pituitary Macroadenoma
por: Naik, Vaishali Shashikant
Publicado: (2022)

Transcription Factor NAC075 Delays Leaf Senescence by Deterring Reactive Oxygen Species Accumulation in Arabidopsis
por: Kan, Chengcheng, et al.
Publicado: (2021)

Destabilization of the replication fork protection complex disrupts meiotic chromosome segregation
por: Escorcia, Wilber, et al.
Publicado: (2017)

Corrigendum: Transcription Factor NAC075 Delays Leaf Senescence by Deterring Reactive Oxygen Species Accumulation in Arabidopsis
por: Kan, Chengcheng, et al.
Publicado: (2021)

Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration
por: Horibata, Sachi, et al.
Publicado: (2017)

Natural Product Celastrol Destabilizes Tubulin Heterodimer and Facilitates Mitotic Cell Death Triggered by Microtubule-Targeting Anti-Cancer Drugs
por: Jo, Hakryul, et al.
Publicado: (2010)

Characterization of Microtubule Destabilizing Drugs: A Quantitative Cell-Based Assay That Bridges the Gap between Tubulin Based- and Cytotoxicity Assays
por: Laisne, Marie-Catherine, et al.
Publicado: (2021)

Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease
por: Peris, Leticia, et al.
Publicado: (2022)

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
por: Sheng, Yuqiao, et al.
Publicado: (2016)

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
por: Hsu, Yung Chang, et al.
Publicado: (2016)

Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2010)

BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways
por: Leu, Jyh-Der, et al.
Publicado: (2022)

3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells
por: Wang, Shu, et al.
Publicado: (2019)

Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction
por: Wattanathamsan, Onsurang, et al.
Publicado: (2023)

The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
por: Liu, Yingying, et al.
Publicado: (2010)

Stress-Tolerant Endophytic Isolate Priestia aryabhattai BPR-9 Modulates Physio-Biochemical Mechanisms in Wheat (Triticum aestivum L.) for Enhanced Salt Tolerance
por: Shahid, Mohammad, et al.
Publicado: (2022)

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment
por: Liu, Li, et al.
Publicado: (2022)

Establishment and Characterization of Feline Mammary Tumor Patient-Derived Xenograft Model
por: Chuang, Hsiao-Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0uia9a4mnaol21ukdn99d5bj4